Piramal Pharma Limited (NSE:PPLPHARMA)

India flag India · Delayed Price · Currency is INR
220.00
-3.62 (-1.62%)
Apr 24, 2025, 2:30 PM IST
54.88%
Market Cap 296.46B
Revenue (ttm) 89.49B
Net Income (ttm) 389.00M
Shares Out 1.33B
EPS (ttm) 0.29
PE Ratio 762.12
Forward PE 127.78
Dividend 0.11 (0.05%)
Ex-Dividend Date n/a
Volume 4,233,838
Average Volume 9,276,757
Open 224.10
Previous Close 223.62
Day's Range 219.51 - 228.15
52-Week Range 136.10 - 307.90
Beta 0.10
RSI 57.28
Earnings Date May 9, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which off... [Read more]

Sector Healthcare
Founded 2020
Employees 6,719
Stock Exchange National Stock Exchange of India
Ticker Symbol PPLPHARMA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.